Honorary Professor

Nathan Subramaniam

Email: 

Availability

Honorary Professor Nathan Subramaniam is:
Available for supervision

Fields of research

Biological Sciences Clinical sciences Oncology and carcinogenesis

Qualifications

  • PhD, Purdue University USA
  • BSc, Rajasthan University India
  • MSc, Bombay University India

Search Professor Nathan Subramaniam’s works on UQ eSpace

211 works between 1991 and 2024
All (211) Journal Article (130) Book Chapter (2) Conference Publication (79)

161 - 180 of 211 works

2005

Journal Article

First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin

Wallace, D. F., Summerville, L., Lusby, P. E. and Subramaniam, V. N. (2005). First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut, 54 (7), 980-986. doi: 10.1136/gut.2004.062018

First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin

2005

Journal Article

Identification of ferroportin disease in the Indian subcontinent

Wallace, D. F., Browett, P., Wong, P., Kua, H., Ameratunga, R. and Subramaniam, V. N. (2005). Identification of ferroportin disease in the Indian subcontinent. Gut, 54 (4), 567-568. doi: 10.1136/gut.2004.060988

Identification of ferroportin disease in the Indian subcontinent

2005

Journal Article

Mammalian Bet3 functions as a cytosolic factor participating in transport from the ER to the Golgi apparatus

Loh, Eva, Peter, Frank, Subramaniam, V. Nathan and Hong, Wanjin (2005). Mammalian Bet3 functions as a cytosolic factor participating in transport from the ER to the Golgi apparatus. Journal of Cell Science, 118 (6), 1209-1222. doi: 10.1242/jcs.01723

Mammalian Bet3 functions as a cytosolic factor participating in transport from the ER to the Golgi apparatus

2005

Journal Article

Hemojuvelin (HJV)-associated hemochromatosis: Analysis of HJV and HFE mutations and iron overload in three families

Wallace, Daniel F., Dixon, Jeannette L., Ramm, Grant A., Anderson, Gregory J., Powell, Lawrie W. and Subramaniam, Nathan (2005). Hemojuvelin (HJV)-associated hemochromatosis: Analysis of HJV and HFE mutations and iron overload in three families. Haematologica, 90 (2), 254-255.

Hemojuvelin (HJV)-associated hemochromatosis: Analysis of HJV and HFE mutations and iron overload in three families

2005

Conference Publication

Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease

Anderson, Greg, Frazer, David M., Bridle, Kim R., Macdonald, Graeme A., Smith, Jeffrey L., Turlin, Bruno, Subramaniam, Nathan, Crawford, Darrell H., Powell, Lawrie W. and Ramm, Grant A. (2005). Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease. 47th Annual Meeting of the American Society of Hematology, Atlanta, Georgia, USA, 10-13 December, 2005. Washington, D.C., USA: American Society of Hematology.

Expression of the iron regulatory peptide hepcidin is reduced in patients with chronic liver disease

2005

Conference Publication

Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.

Powell, LW, Dixon, JL, Anderson, GA, Subramaniam, VN, Lincoln, DJ, Fletcher, LM, Crawford, DH, Searle, JW and Ramm, GA (2005). Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.. 56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, San Francisco CA, NOV 11-15, 2005. HOBOKEN: JOHN WILEY & SONS INC.

Hepatic fibrosis but not cirrhosis in hemochromatosis is reversed by iron removal by phlebotomy therapy.

2005

Journal Article

Ferroportin disease due to the A77D mutation in Australia

Subramaniam, V. N., Wallace, D. F., Dixon, J. L., Fletcher, L. M. and Crawford, D. H. (2005). Ferroportin disease due to the A77D mutation in Australia. Gut, 54 (7), 1048-1049. doi: 10.1136/gut.2005.069021

Ferroportin disease due to the A77D mutation in Australia

2004

Journal Article

Genetic disorders in gastroenterology and hepatology - HFE gene and hemochromatosis

Ramm, G. A., Subramaniam, V. N. and Powell, L. W. (2004). Genetic disorders in gastroenterology and hepatology - HFE gene and hemochromatosis. Journal of Gastroenterology and Hepatology, 19 (6), 712-712. doi: 10.1111/j.0815-9319.2004.03499.x

Genetic disorders in gastroenterology and hepatology - HFE gene and hemochromatosis

2004

Journal Article

Inactivation of the murine Transferrin receptor 2 gene using the Cre recombinase: IoxP system

Wallace, Daniel F., Tonks, Ian D., Zournazi, Anna, Kay, Graham F. and Subramaniam, V. Nathan (2004). Inactivation of the murine Transferrin receptor 2 gene using the Cre recombinase: IoxP system. Genesis, 39 (1), 38-41. doi: 10.1002/gene.20023

Inactivation of the murine Transferrin receptor 2 gene using the Cre recombinase: IoxP system

2004

Journal Article

Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis

Wallace, Daniel F., Clark, Roslyn M., Harley, Hugh A. J. and Subramaniam, V. Nathan (2004). Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis. Journal of Hepatology, 40 (4), 710-713. doi: 10.1016/j.jhep.2003.12.008

Autosomal dominant iron overload due to a novel mutation of ferroportin1 associated with parenchymal iron loading and cirrhosis

2004

Journal Article

Reply

Anderson, Gregory J., Frazer, David M., Bridle, Kim R., Crawford, Darell H. G., Subramaniam, V. Nathan, Powell, Lawrie W. and Ramm, Grant A. (2004). Reply. Gastroenterology, 126 (2), 616-616. doi: 10.1053/j.gastro.2003.12.054

Reply

2004

Conference Publication

The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screening

Powell, L. W., Dixon, J. L., Ramm, G. A., Anderson, G. J., Subramaniam, V. N., Purdie, D. M., Hewett, D. G., Searle, J. W., Fletcher, L. M., Crawford, D. H., Rodgers, H., Khoo, T. L., Cavanaugh, J. A. and Bassett, M. L. (2004). The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screening. 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Boston MA, 29 October - 2 November 2004. HOBOKEN: JOHN WILEY & SONS INC.

The penetrance of HFE-associated hemochromatosis as assessed by clinical evaluation and liver biopsy in subjects identified by health checks, family screening or population screening

2003

Journal Article

Ironing out doxorubicin-related cardiotoxicity

Subramaniam, V. N. (2003). Ironing out doxorubicin-related cardiotoxicity. Blood, 102 (7), 2317-2318. doi: 10.1182/blood-2003-07-2517

Ironing out doxorubicin-related cardiotoxicity

2003

Journal Article

A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient

ArdenKE, WallaceDF, DixonJL, SummervilleL, SearleJW, AndersonGJ, RammGA, PowellLW and Subramaniam, V. N. (2003). A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut, 52 (8), 1215-1217. doi: 10.1136/gut.52.8.1215

A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient

2003

Journal Article

Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis

Bridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Purdie, D. M., Crawford, D. H. G., Subramaniam, V. N, Powell, L. W., Anderson, G. J. and Ramm, G. A. (2003). Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet, 361 (9358), 669-673. doi: 10.1016/S0140-6736(03)12602-5

Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis

2003

Conference Publication

Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance

Powell, L. W., Dixon, J. L., Hewett, D. G., Purdie, D. M., Ramm, G. A., Anderson, G. J., Subramaniam, N., Fletcher, L. M., Crawford, D. H., Cavanaugh, J. A. and Bassett, M. L. (2003). Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance. 54th Annual Meeting of the American Association for the Study of Liver Disease, Boston, MA, United States, 24-28 October 2003. PHILADELPHIA: W B SAUNDERS CO.

Rates of iron accumulation in untreated subjects homozygous for the C282Y hemochromatosis mutation: Relevance to disease penetrance

2003

Conference Publication

Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasis

Bridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Millard, K. N., Crawford, D. H. G., Subramaniam, V. N., Powell, L. W., Anderson, G. J. and Ramm , G. A. (2003). Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasis. Australian Gastroenterology Week, Cairns, Australia, 7-10 October 2003. Carlton South, Vic., Australia: Blackwell Publishing Asia. doi: 10.1046/j.1440-1746.18.s2.5.x

Failure of hepcidin upregulation in HFE-associated haemochromatosis implicates the liver in the regulation of body iron homeostasis

2003

Conference Publication

The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D)

Hewett, D. G.., Dixon, J. L., Purdie, D. M., Ramm, G. A., Anderson, G. J., Subramaniam, N., Fletcher, L. M., Crawford, D. H., Cavanaugh, J. A., Bassett, M. L. and Powell, L. W. (2003). The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D). 54th Annual Meeting of the American Association for the Study of Liver Disease, Boston, M.A. USA, 24-28 October 2003. PHILADELPHIA: W B SAUNDERS CO.

The clinical relevance of compound heterozygosity for the hemochromatosis mutations (C282Y/H63D)

2002

Conference Publication

Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.

Powell, L, Dixon, JL, Ramm, G, Anderson, G, Subramaniam, N, Fletcher, L, Crawford, D, Cavanaugh, J and Bassett, M (2002). Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.. 53rd Annual Meeting of the Association-for-the-Study-of-Liver-Diseases (AASLD), Boston Massachusetts, Nov 01-05, 2002. PHILADELPHIA: W B SAUNDERS CO.

Phenotypic expression of hfe-associated hemochromatosis in C282Y homozygous relatives: Implications for screening.

2002

Journal Article

Novel mutation in ferroponin1 is associated with autosomal dominant hemochromatosis

Wallace, Daniel F., Pedersen, Palle, Dixon, Jeannette L., Stephenson, Peter, Searle, Jeffrey W., Powell, Lawrie W. and Subramaniam, V. Nathan (2002). Novel mutation in ferroponin1 is associated with autosomal dominant hemochromatosis. Blood, 100 (2), 692-694. doi: 10.1182/blood.V100.2.692

Novel mutation in ferroponin1 is associated with autosomal dominant hemochromatosis

Past funding

  • 2014 - 2019
    Immunotherapeutic Approaches for Hepatocellular Carcinoma
    Gallipoli Medical Research Foundation
    Open grant

Availability

Honorary Professor Nathan Subramaniam is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Completed supervision

Enquiries

For media enquiries about Honorary Professor Nathan Subramaniam's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au